Although in vitro studies showed that remdesivir reduced IL-6 production induced by human coronavirus OC43 in human lung fibroblasts [34], little is available on the effect of remdesivir on the inflammatory response in clinical studies on COVID-19. Here, IL6 is linked to COVID-19.